Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
small cell lung cancer
Biotech
Roche returns to MediLink with $570M near-term payments for ADC
Roche has got in on the B7-H3 action, agreeing to $570 million in near-term payments to partner MediLink Therapeutics for an ADC targeting the protein
James Waldron
Jan 9, 2026 5:40am
BioNTech, BMS tout first global data for PD-L1xVEGF drug in SCLC
Sep 8, 2025 11:00am
Daiichi, Merck rev up for accelerated approval filing
Sep 7, 2025 10:45am
BioNTech posts survival data behind bispecific's phase 3 push
Mar 28, 2025 8:00am
Chasing Merck, BioNTech, DualityBio post first data on ADC
Dec 6, 2024 9:07am
Merck, Daiichi repeat early success in small cell lung cancer
Sep 9, 2024 10:27am
